375 related articles for article (PubMed ID: 33142238)
21. Metabolic and inflammatory reprogramming of macrophages by ONC201 translates in a pro-inflammatory environment even in presence of glioblastoma cells.
Geiß C; Witzler C; Poschet G; Ruf W; Régnier-Vigouroux A
Eur J Immunol; 2021 May; 51(5):1246-1261. PubMed ID: 33442873
[TBL] [Abstract][Full Text] [Related]
22. Small molecule ONC201 inhibits HIV-1 replication in macrophages via FOXO3a and TRAIL.
Zhao R; Li Y; Gorantla S; Poluektova LY; Lin H; Gao F; Wang H; Zhao J; Zheng JC; Huang Y
Antiviral Res; 2019 Aug; 168():134-145. PubMed ID: 31158413
[TBL] [Abstract][Full Text] [Related]
23. Microarray analysis reveals ONC201 mediated differential mechanisms of CHOP gene regulation in metastatic and nonmetastatic colorectal cancer cells.
Al Madhoun A; Haddad D; Al Tarrah M; Jacob S; Al-Ali W; Nizam R; Miranda L; Al-Rashed F; Sindhu S; Ahmad R; Bitar MS; Al-Mulla F
Sci Rep; 2021 Jun; 11(1):11893. PubMed ID: 34088951
[TBL] [Abstract][Full Text] [Related]
24. Dual inactivation of Akt and ERK by TIC10 signals Foxo3a nuclear translocation, TRAIL gene induction, and potent antitumor effects.
Allen JE; Krigsfeld G; Mayes PA; Patel L; Dicker DT; Patel AS; Dolloff NG; Messaris E; Scata KA; Wang W; Zhou JY; Wu GS; El-Deiry WS
Sci Transl Med; 2013 Feb; 5(171):171ra17. PubMed ID: 23390247
[TBL] [Abstract][Full Text] [Related]
25. Small Molecular TRAIL Inducer ONC201 Induces Death in Lung Cancer Cells: A Preclinical Study.
Feng Y; Zhou J; Li Z; Jiang Y; Zhou Y
PLoS One; 2016; 11(9):e0162133. PubMed ID: 27626799
[TBL] [Abstract][Full Text] [Related]
26. Highly potent dopamine receptor D2 antagonist ONC206 demonstrates anti-tumorigenic activity in endometrial cancer.
Staley A; Tucker K; Yin Y; Zhang X; Fan Y; Zhang Y; Fang Z; Sun W; Suo H; Zhao X; Zhao Z; Prabhu VV; Allen JE; Zhou C; Bae-Jump VL
Am J Cancer Res; 2021; 11(11):5374-5387. PubMed ID: 34873466
[TBL] [Abstract][Full Text] [Related]
27. ONC201/TIC10 enhances durability of mTOR inhibitor everolimus in metastatic ER+ breast cancer.
Farmaki E; Nath A; Emond R; Karimi KL; Grolmusz VK; Cosgrove PA; Bild AH
Elife; 2023 Sep; 12():. PubMed ID: 37772709
[TBL] [Abstract][Full Text] [Related]
28. ONC201 Shows Potent Anticancer Activity Against Medullary Thyroid Cancer via Transcriptional Inhibition of
Bagheri-Yarmand R; Dadu R; Ye L; Shiny Jebaraj Y; Martinez JA; Ma J; Tarapore RS; Allen JE; Sherman SI; Williams MD; Gagel RF
Mol Cancer Ther; 2021 Apr; 20(4):665-675. PubMed ID: 33536187
[TBL] [Abstract][Full Text] [Related]
29. Modulating the unfolded protein response with ONC201 to impact on radiation response in prostate cancer cells.
Amoroso F; Glass K; Singh R; Liberal F; Steele RE; Maguire S; Tarapore R; Allen JE; Van Schaeybroeck S; Butterworth KT; Prise K; O'Sullivan JM; Jain S; Waugh DJ; Mills IG
Sci Rep; 2021 Feb; 11(1):4252. PubMed ID: 33608585
[TBL] [Abstract][Full Text] [Related]
30. Targeting dopamine receptor D2 as a novel therapeutic strategy in endometrial cancer.
Pierce SR; Fang Z; Yin Y; West L; Asher M; Hao T; Zhang X; Tucker K; Staley A; Fan Y; Sun W; Moore DT; Xu C; Tsai YH; Parker J; Prabhu VV; Allen JE; Lee D; Zhou C; Bae-Jump V
J Exp Clin Cancer Res; 2021 Feb; 40(1):61. PubMed ID: 33557912
[TBL] [Abstract][Full Text] [Related]
31. First-In-Class Small Molecule ONC201 Induces DR5 and Cell Death in Tumor but Not Normal Cells to Provide a Wide Therapeutic Index as an Anti-Cancer Agent.
Allen JE; Crowder RN; El-Deiry WS
PLoS One; 2015; 10(11):e0143082. PubMed ID: 26580220
[TBL] [Abstract][Full Text] [Related]
32. Imipridone ONC212 activates orphan G protein-coupled receptor GPR132 and integrated stress response in acute myeloid leukemia.
Nii T; Prabhu VV; Ruvolo V; Madhukar N; Zhao R; Mu H; Heese L; Nishida Y; Kojima K; Garnett MJ; McDermott U; Benes CH; Charter N; Deacon S; Elemento O; Allen JE; Oster W; Stogniew M; Ishizawa J; Andreeff M
Leukemia; 2019 Dec; 33(12):2805-2816. PubMed ID: 31127149
[TBL] [Abstract][Full Text] [Related]
33. ONC201 kills solid tumor cells by triggering an integrated stress response dependent on ATF4 activation by specific eIF2α kinases.
Kline CL; Van den Heuvel AP; Allen JE; Prabhu VV; Dicker DT; El-Deiry WS
Sci Signal; 2016 Feb; 9(415):ra18. PubMed ID: 26884600
[TBL] [Abstract][Full Text] [Related]
34. The Imipridone ONC201 Induces Apoptosis and Overcomes Chemotherapy Resistance by Up-Regulation of Bim in Multiple Myeloma.
Tu YS; He J; Liu H; Lee HC; Wang H; Ishizawa J; Allen JE; Andreeff M; Orlowski RZ; Davis RE; Yang J
Neoplasia; 2017 Oct; 19(10):772-780. PubMed ID: 28863346
[TBL] [Abstract][Full Text] [Related]
35. ONC201 Demonstrates Antitumor Effects in Both Triple-Negative and Non-Triple-Negative Breast Cancers through TRAIL-Dependent and TRAIL-Independent Mechanisms.
Ralff MD; Kline CLB; Küçükkase OC; Wagner J; Lim B; Dicker DT; Prabhu VV; Oster W; El-Deiry WS
Mol Cancer Ther; 2017 Jul; 16(7):1290-1298. PubMed ID: 28424227
[TBL] [Abstract][Full Text] [Related]
36. Dual metabolic reprogramming by ONC201/TIC10 and 2-Deoxyglucose induces energy depletion and synergistic anti-cancer activity in glioblastoma.
Pruss M; Dwucet A; Tanriover M; Hlavac M; Kast RE; Debatin KM; Wirtz CR; Halatsch ME; Siegelin MD; Westhoff MA; Karpel-Massler G
Br J Cancer; 2020 Apr; 122(8):1146-1157. PubMed ID: 32115576
[TBL] [Abstract][Full Text] [Related]
37. ONC201 Targets AR and AR-V7 Signaling, Reduces PSA, and Synergizes with Everolimus in Prostate Cancer.
Lev A; Lulla AR; Ross BC; Ralff MD; Makhov PB; Dicker DT; El-Deiry WS
Mol Cancer Res; 2018 May; 16(5):754-766. PubMed ID: 29588330
[TBL] [Abstract][Full Text] [Related]
38. Dose intensification of TRAIL-inducing ONC201 inhibits metastasis and promotes intratumoral NK cell recruitment.
Wagner J; Kline CL; Zhou L; Campbell KS; MacFarlane AW; Olszanski AJ; Cai KQ; Hensley HH; Ross EA; Ralff MD; Zloza A; Chesson CB; Newman JH; Kaufman H; Bertino J; Stein M; El-Deiry WS
J Clin Invest; 2018 Jun; 128(6):2325-2338. PubMed ID: 29533922
[TBL] [Abstract][Full Text] [Related]
39. Combined Drug Targeting of p53-dependent and -independent Pathways Depletes Myelofibrosis Hematopoietic Stem/Progenitor Cells.
Lu M; Xia L; Elmansy N; Clementelli C; Tremblay D; Hoffman R
Leukemia; 2022 Mar; 36(3):733-745. PubMed ID: 34642468
[TBL] [Abstract][Full Text] [Related]
40. The preclinical evaluation of TIC10/ONC201 as an anti-pancreatic cancer agent.
Zhang Q; Wang H; Ran L; Zhang Z; Jiang R
Biochem Biophys Res Commun; 2016 Aug; 476(4):260-266. PubMed ID: 27233611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]